bibliographic resource 4723821 [br/4723821]
https://w3id.org/oc/corpus/br/4723821
- is a
-
- title
-
- Mutations within the EGFR signaling pathway: Influence on efficacy in FIRE-3âA randomized phase III study of FOLFIRI plus cetuximab or bevacizumab as first-line treatment for wild-type (WT) KRAS (exon 2) metastatic colorectal cancer (mCRC) patients.
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-